Anti-lymphoma effects of mono/combination therapy with anti-CD20 and anti-HL-DR mabs in human lymphoma cell lines

被引：0
|
作者：
DeNardo, G [1 ]
Tobin, E [1 ]
Chan, K [1 ]
Bradt, B [1 ]
DeNardo, S [1 ]
机构：
[1] Univ Calif Davis, Med Ctr, Davis, CA 95616 USA
来源：
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2004年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页码：512 / 513
页数：2
相关论文
共 50 条
  • [21] Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
    Alinari, Lapo
    Yu, Bo
    Christian, Beth A.
    Yan, Fengting
    Shin, Jungook
    Lapalombella, Rosa
    Hertlein, Erin
    Lustberg, Mark E.
    Quinion, Carl
    Zhang, Xiaoli
    Lozanski, Gerard
    Muthusamy, Natarajan
    Praetorius-Ibba, Mette
    O'Connor, Owen A.
    Goldenberg, David M.
    Byrd, John C.
    Blum, Kristie A.
    Baiocchi, Robert A.
    BLOOD, 2011, 117 (17) : 4530 - 4541
  • [22] Combination monoclonal antibody therapy for lymphoma: Treatment with epratuzumab (anti-CD22) and rituximab (anti-CD20) is well tolerated.
    Leonard, JP
    Coleman, M
    Matthews, JC
    Fiore, JM
    Dosik, A
    Kapushoc, H
    Kin, E
    Cesano, A
    Wegener, WA
    Goldenberg, DM
    BLOOD, 2001, 98 (11) : 844A - 844A
  • [23] Bispecific Anti-CD20/Anti-CD22 Antibodies with Potent Lymphoma Cytotoxicity
    Rossi, Edmund A.
    Chang, Chien-Hsing
    Cardillo, Thomas M.
    Stein, Rhona
    Pilas, Diana
    Nordstrom, Diane L.
    Kopinski, John
    Goldenberg, David M.
    BLOOD, 2008, 112 (11) : 564 - 565
  • [24] Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva
    Nückel, H
    Meller, D
    Steuhl, KP
    Dührsen, U
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (04) : 258 - 262
  • [25] Peripheral T-cell lymphoma after anti-CD20 antibody therapy - In reply
    Maloney, DG
    Davis, T
    Levy, R
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1636 - 1637
  • [26] Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity
    Lv, Ming
    Lin, Zhou
    Qiao, Chunxia
    Gen, Shusheng
    Lang, Xiaoling
    Li, Yan
    Feng, Jiannan
    Shen, Beifen
    CANCER LETTERS, 2010, 294 (01) : 66 - 73
  • [27] Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    Armitage, James O.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1389 - 1390
  • [28] Combination Therapy with FTY720 (Fingolimod) and Bispecific Anti-CD20/CD74 Antibodies in Mantle Cell Lymphoma
    Gupta, Pankaj
    Michel, Rosana
    Goldenberg, David M.
    Chang, Chien-Hsing
    BLOOD, 2011, 118 (21) : 1595 - 1595
  • [29] Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody
    Kyohei Nakamura
    Mika Casey
    Harald Oey
    Frank Vari
    John Stagg
    Maher K. Gandhi
    Mark J. Smyth
    Leukemia, 2020, 34 : 2708 - 2721
  • [30] Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibody
    Nakamura, Kyohei
    Casey, Mika
    Oey, Harald
    Vari, Frank
    Stagg, John
    Gandhi, Maher K.
    Smyth, Mark J.
    LEUKEMIA, 2020, 34 (10) : 2708 - 2721
12345